The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis

Phase 2

Completed

• Conditions: General Disorders and Administration Site Conditions
• Interventions: Drug: Tangning Tongluo Capsule

• Registration Number: NCT02174042
• Lead Sponsor: Guizhou Bailing Group Pharmaceutical Co Ltd

Brief Summary

The aim of this retrospective study is to review and describe safety and efficacy of Tang Ning Tong Luo capsule.

Detailed Description

The aim of this retrospective study is to review and describe safety and efficacy of Tang Ning Tong Luo capsule,a traditional Chinese Miao medicine, in Type 2 Diabetics.

Study Timeline

• Study Start: 2014-03
• Study First Submitted: 2014-06-23
• Study First Submitted QC: 2014-06-24
• Study First Posted: 2014-06-25
• Primary Completion: 2014-08
• Status Verified: 2014-09
• Study Completion: 2014-09
• Last Update Submitted: 2014-09-09
• Last Update Posted: 2014-09-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Tangning Tongluo Capsule	Tangning Tongluo Capsule	Type 2 diabetes

Primary Outcome Measures

Name	Time	Method
The Changing (%) of Blood Glucose Level and Glycosylated Hemoglobin Level from Baseline	At least 3 months	The Changing (%) of Blood Glucose Level (mmol/L) and Glycosylated Hemoglobin Level (%) from Baseline (start using Tang Ning Tong Luo capsule) in recruited Type 2 diabetes patients.

Secondary Outcome Measures

Name	Time	Method
The Number of Participants with Adverse Events Using Tangning Tongluo Capsule	At least 3 months	The Number of Participants with Adverse Events Using Tangning Tongluo Capsule in the Treatment ofType II Diabetes

Trial Locations

Locations (1)

Nanmeng Tianyuan hospital; Dongfang Hospital; China-Japanese Friendship Hospital; 🇨🇳 Beijing Shi, Guizhou, China